We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck and Idera Agree to Vaccine Collaboration
Merck and Idera Agree to Vaccine Collaboration
December 11, 2006
Merck and Idera Pharmaceuticals announced a collaboration to incorporate Idera’s toll-like receptor (TLR) agonists into vaccines Merck is developing for oncology, infectious diseases and Alzheimer’s disease.